Bioinformatics Analysis of the SIRT Family Members and Assessment of Their Potential Clinical Value

References

• Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. doi:10.3322/caac.21262
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Testino G, Leone S, Patussi V, Scafato E, Borro P. Hepatocellular carcinoma: diagnosis and proposal of treatment. Minerva Med. 2016;107(6):413–426.
   PubMed Web of Science ®Google Scholar
• de Martel C, Ferlay J, Franceschi S, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol. 2012;13(6):607–615. doi:10.1016/s1470-2045(12)70137-7
   PubMed Web of Science ®Google Scholar
• Carafa V, Rotili D, Forgione M, et al. Sirtuin functions and modulation: from chemistry to the clinic. Clin Epigenetics. 2016;8(1):61. doi:10.1186/s13148-016-0224-3
   PubMedGoogle Scholar
• Mendes KL, Lelis DF, Santos SHS. Nuclear sirtuins and inflammatory signaling pathways. Cytokine Growth Factor Rev. 2017;38:98–105. doi:10.1016/j.cytogfr.2017.11.001
   PubMed Web of Science ®Google Scholar
• Houtkooper RH, Pirinen E, Auwerx J. Sirtuins as regulators of metabolism and healthspan. Nat Rev Mol Cell Biol. 2012;13(4):225–238. doi:10.1038/nrm3293
   PubMed Web of Science ®Google Scholar
• Wątroba M, Dudek I, Skoda M, Stangret A, Rzodkiewicz P, Szukiewicz D. Sirtuins, epigenetics and longevity. Ageing Res Rev. 2017;40:11–19. doi:10.1016/j.arr.2017.08.001
   PubMed Web of Science ®Google Scholar
• Vargas-Ortiz K, Pérez-Vázquez V, Macías-Cervantes MH. Exercise and sirtuins: a way to mitochondrial health in skeletal muscle. Int J Mol Sci. 2019;20(11):2717. doi:10.3390/ijms20112717
   PubMed Web of Science ®Google Scholar
• Hwang JW, Yao H, Caito S, Sundar IK, Rahman I. Redox regulation of SIRT1 in inflammation and cellular senescence. Free Radic Biol Med. 2013;61:95–110. doi:10.1016/j.freeradbiomed.2013.03.015
   PubMed Web of Science ®Google Scholar
• Chen Y, Fu LL, Wen X, et al. Sirtuin-3 (SIRT3), a therapeutic target with oncogenic and tumor-suppressive function in cancer. Cell Death Dis. 2014;5(2):e1047. doi:10.1038/cddis.2014.14
   PubMedGoogle Scholar
• Min Z, Gao J, Yu Y. The roles of mitochondrial SIRT4 in cellular metabolism. Front Endocrinol (Lausanne). 2018;9:783. doi:10.3389/fendo.2018.00783
   PubMed Web of Science ®Google Scholar
• Bringman-Rodenbarger LR, Guo AH, Lyssiotis CA, Lombard DB. Emerging roles for SIRT5 in metabolism and cancer. Antioxid Redox Signal. 2018;28(8):677–690. doi:10.1089/ars.2017.7264
   PubMed Web of Science ®Google Scholar
• Tasselli L, Zheng W, Chua KF. SIRT6: novel mechanisms and links to aging and disease. Trends Endocrinol Metab. 2017;28(3):168–185. doi:10.1016/j.tem.2016.10.002
   PubMed Web of Science ®Google Scholar
• Wu D, Li Y, Zhu KS, Wang H, Zhu WG. Advances in cellular characterization of the sirtuin isoform, SIRT7. Front Endocrinol (Lausanne). 2018;9:652. doi:10.3389/fendo.2018.00652
   PubMed Web of Science ®Google Scholar
• Wen X, Ling S, Wu W, et al. Ubiquitin-specific protease 22/silent information regulator 1 axis plays a pivotal role in the prognosis and 5-fluorouracil resistance in hepatocellular carcinoma. Dig Dis Sci. 2020;65(4):1064–1073. doi:10.1007/s10620-019-05844-8
   PubMed Web of Science ®Google Scholar
• Wang JX, Yi Y, Li YW, et al. Down-regulation of sirtuin 3 is associated with poor prognosis in hepatocellular carcinoma after resection. BMC Cancer. 2014;14(1):297. doi:10.1186/1471-2407-14-297
   PubMedGoogle Scholar
• Rhodes DR, Kalyana-Sundaram S, Mahavisno V, et al. Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia. 2007;9(2):166–180. doi:10.1593/neo.07112
   PubMed Web of Science ®Google Scholar
• Chandrashekar DS, Bashel B, Balasubramanya SAH, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017;19(8):649–658. doi:10.1016/j.neo.2017.05.002
   PubMed Web of Science ®Google Scholar
• Blum A, Wang P, Zenklusen JC. SnapShot: TCGA-analyzed tumors. Cell. 2018;173(2):530. doi:10.1016/j.cell.2018.03.059
   PubMed Web of Science ®Google Scholar
• Vasaikar SV, Straub P, Wang J, Zhang B. LinkedOmics: analyzing multi-omics data within and across 32 cancer types. Nucleic Acids Res. 2018;46(D1):D956–D963. doi:10.1093/nar/gkx1090
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhou B, Pache L, Chang M. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1523. doi:10.1038/s41467-019-09234-6
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Gable AL, Lyon D, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607–D613. doi:10.1093/nar/gky1131
   PubMed Web of Science ®Google Scholar
• Tsuchida T, Lee YA, Fujiwara N, et al. A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer. J Hepatol. 2018;69(2):385–395. doi:10.1016/j.jhep.2018.03.011
   PubMed Web of Science ®Google Scholar
• Chun YH, Kim SU, Park JY, et al. Prognostic value of the 7th edition of the AJCC staging system as a clinical staging system in patients with hepatocellular carcinoma. Eur J Cancer. 2011;47(17):2568–2575. doi:10.1016/j.ejca.2011.07.002
   PubMed Web of Science ®Google Scholar
• George J, Ahmad N. Mitochondrial sirtuins in cancer: emerging roles and therapeutic potential. Cancer Res. 2016;76(9):2500–2506. doi:10.1158/0008-5472.can-15-2733
   PubMed Web of Science ®Google Scholar
• Olmos Y, Brosens JJ, Lam EW. Interplay between SIRT proteins and tumour suppressor transcription factors in chemotherapeutic resistance of cancer. Drug Resist Updat. 2011;14(1):35–44. doi:10.1016/j.drup.2010.12.001
   PubMed Web of Science ®Google Scholar
• Torrens-Mas M, Oliver J, Roca P, Sastre-Serra J. SIRT3: oncogene and tumor suppressor in cancer. Cancers (Basel). 2017;9(7):90. doi:10.3390/cancers9070090
   PubMed Web of Science ®Google Scholar
• Wei Z, Song J, Wang G, et al. Deacetylation of serine hydroxymethyl-transferase 2 by SIRT3 promotes colorectal carcinogenesis. Nat Commun. 2018;9(1):4468. doi:10.1038/s41467-018-06812-y
   PubMedGoogle Scholar
• Cui Y, Qin L, Wu J, et al. SIRT3 enhances glycolysis and proliferation in SIRT3-expressing gastric cancer cells. PLoS One. 2015;10(6):e0129834. doi:10.1371/journal.pone.0129834
   PubMed Web of Science ®Google Scholar
• Yang GC, Fu BC, Zhang DY, et al. The expression and related clinical significance of SIRT3 in non-small-cell lung cancer. Dis Markers. 2017;2017:8241953. doi:10.1155/2017/8241953
   PubMed Web of Science ®Google Scholar
• Liu H, Li S, Liu X, Chen Y, Deng H. SIRT3 overexpression inhibits growth of kidney tumor cells and enhances mitochondrial biogenesis. J Proteome Res. 2018;17(9):3143–3152. doi:10.1021/acs.jproteome.8b00260
   PubMed Web of Science ®Google Scholar
• Li R, Quan Y, Xia W. SIRT3 inhibits prostate cancer metastasis through regulation of FOXO3A by suppressing Wnt/β-catenin pathway. Exp Cell Res. 2018;364(2):143–151. doi:10.1016/j.yexcr.2018.01.036
   PubMed Web of Science ®Google Scholar
• Finley LW, Carracedo A, Lee J, et al. SIRT3 opposes reprogramming of cancer cell metabolism through HIF1α destabilization. Cancer Cell. 2011;19(3):416–428. doi:10.1016/j.ccr.2011.02.014
   PubMed Web of Science ®Google Scholar
• Vitiello M, Zullo A, Servillo L, et al. Multiple pathways of SIRT6 at the crossroads in the control of longevity, cancer, and cardiovascular diseases. Ageing Res Rev. 2017;35:301–311. doi:10.1016/j.arr.2016.10.008
   PubMed Web of Science ®Google Scholar
• Ioris RM, Galié M, Ramadori G, et al. SIRT6 suppresses cancer stem-like capacity in tumors with PI3K activation independently of its deacetylase activity. Cell Rep. 2017;18(8):1858–1868. doi:10.1016/j.celrep.2017.01.065
   PubMed Web of Science ®Google Scholar
• Kugel S, Sebastián C, Fitamant J, et al. SIRT6 suppresses pancreatic cancer through control of Lin28b. Cell. 2016;165(6):1401–1415. doi:10.1016/j.cell.2016.04.033
   PubMed Web of Science ®Google Scholar
• Ming M, Han W, Zhao B, et al. SIRT6 promotes COX-2 expression and acts as an oncogene in skin cancer. Cancer Res. 2014;74(20):5925–5933. doi:10.1158/0008-5472.can-14-1308
   PubMed Web of Science ®Google Scholar
• Qi J, Cui C, Deng Q, et al. Downregulated SIRT6 and upregulated NMNAT2 are associated with the presence, depth and stage of colorectal cancer. Oncol Lett. 2018;16(5):5829–5837. doi:10.3892/ol.2018.9400
   PubMed Web of Science ®Google Scholar
• Chen T, Sun Z, Liu F, Wang Q. RASSF1A and SIRT6 in non-small cell lung cancer: relationship with clinical outcome. Oncol Lett. 2017;14(5):5759–5764. doi:10.3892/ol.2017.6172
   PubMed Web of Science ®Google Scholar
• Jeh SU, Park JJ, Lee JS, et al. Differential expression of the sirtuin family in renal cell carcinoma: aspects of carcinogenesis and prognostic significance. Urol Oncol. 2017;35(12):675.e679–675.e615. doi:10.1016/j.urolonc.2017.08.016
   PubMed Web of Science ®Google Scholar
• Bae JS, Park SH, Jamiyandorj U, et al. CK2α/CSNK2A1 phosphorylates SIRT6 and is involved in the progression of breast carcinoma and predicts shorter survival of diagnosed patients. Am J Pathol. 2016;186(12):3297–3315. doi:10.1016/j.ajpath.2016.08.007
   PubMed Web of Science ®Google Scholar
• Tang X, Shi L, Xie N, et al. SIRT7 antagonizes TGF-β signaling and inhibits breast cancer metastasis. Nat Commun. 2017;8(1):318. doi:10.1038/s41467-017-00396-9
   PubMed Web of Science ®Google Scholar
• Huo Q, Li Z, Cheng L, Yang F, Xie N. SIRT7 is a prognostic biomarker associated with immune infiltration in luminal breast cancer. Front Oncol. 2020;10:621. doi:10.3389/fonc.2020.00621
   PubMed Web of Science ®Google Scholar
• Zhang S, Chen P, Huang Z, et al. Sirt7 promotes gastric cancer growth and inhibits apoptosis by epigenetically inhibiting miR-34a. Sci Rep. 2015;5(1):9787. doi:10.1038/srep09787
   PubMedGoogle Scholar